Cargando…

Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study

BACKGROUND: The rise of major complex public health problems, such as vaccination hesitancy and access to vaccination, requires innovative, open, and transdisciplinary approaches. Yet, institutional silos and lack of participation on the part of nonacademic citizens in the design of solutions hamper...

Descripción completa

Detalles Bibliográficos
Autores principales: Masselot, Camille, Greshake Tzovaras, Bastian, Graham, Chris L B, Finnegan, Gary, Jeyaram, Rathin, Vitali, Isabelle, Landrain, Thomas, Santolini, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817221/
https://www.ncbi.nlm.nih.gov/pubmed/35060917
http://dx.doi.org/10.2196/32125
_version_ 1784645596247752704
author Masselot, Camille
Greshake Tzovaras, Bastian
Graham, Chris L B
Finnegan, Gary
Jeyaram, Rathin
Vitali, Isabelle
Landrain, Thomas
Santolini, Marc
author_facet Masselot, Camille
Greshake Tzovaras, Bastian
Graham, Chris L B
Finnegan, Gary
Jeyaram, Rathin
Vitali, Isabelle
Landrain, Thomas
Santolini, Marc
author_sort Masselot, Camille
collection PubMed
description BACKGROUND: The rise of major complex public health problems, such as vaccination hesitancy and access to vaccination, requires innovative, open, and transdisciplinary approaches. Yet, institutional silos and lack of participation on the part of nonacademic citizens in the design of solutions hamper efforts to meet these challenges. Against this background, new solutions have been explored, with participatory research, citizen science, hackathons, and challenge-based approaches being applied in the context of public health. OBJECTIVE: Our aim was to develop a program for creating citizen science and open innovation projects that address the contemporary challenges of vaccination in France and around the globe. METHODS: We designed and implemented Co-Immune, a program created to tackle the question of vaccination hesitancy and access to vaccination through an online and offline challenge-based open innovation approach. The program was run on the open science platform Just One Giant Lab. RESULTS: Over a 6-month period, the Co-Immune program gathered 234 participants of diverse backgrounds and 13 partners from the public and private sectors. The program comprised 10 events to facilitate the creation of 20 new projects, as well as the continuation of two existing projects, to address the issues of vaccination hesitancy and access, ranging from app development and data mining to analysis and game design. In an open framework, the projects made their data, code, and solutions publicly available. CONCLUSIONS: Co-Immune highlights how open innovation approaches and online platforms can help to gather and coordinate noninstitutional communities in a rapid, distributed, and global way toward solving public health issues. Such initiatives can lead to the production and transfer of knowledge, creating novel solutions in the public health sector. The example of Co-Immune contributes to paving the way for organizations and individuals to collaboratively tackle future global challenges.
format Online
Article
Text
id pubmed-8817221
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-88172212022-02-08 Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study Masselot, Camille Greshake Tzovaras, Bastian Graham, Chris L B Finnegan, Gary Jeyaram, Rathin Vitali, Isabelle Landrain, Thomas Santolini, Marc J Particip Med Original Paper BACKGROUND: The rise of major complex public health problems, such as vaccination hesitancy and access to vaccination, requires innovative, open, and transdisciplinary approaches. Yet, institutional silos and lack of participation on the part of nonacademic citizens in the design of solutions hamper efforts to meet these challenges. Against this background, new solutions have been explored, with participatory research, citizen science, hackathons, and challenge-based approaches being applied in the context of public health. OBJECTIVE: Our aim was to develop a program for creating citizen science and open innovation projects that address the contemporary challenges of vaccination in France and around the globe. METHODS: We designed and implemented Co-Immune, a program created to tackle the question of vaccination hesitancy and access to vaccination through an online and offline challenge-based open innovation approach. The program was run on the open science platform Just One Giant Lab. RESULTS: Over a 6-month period, the Co-Immune program gathered 234 participants of diverse backgrounds and 13 partners from the public and private sectors. The program comprised 10 events to facilitate the creation of 20 new projects, as well as the continuation of two existing projects, to address the issues of vaccination hesitancy and access, ranging from app development and data mining to analysis and game design. In an open framework, the projects made their data, code, and solutions publicly available. CONCLUSIONS: Co-Immune highlights how open innovation approaches and online platforms can help to gather and coordinate noninstitutional communities in a rapid, distributed, and global way toward solving public health issues. Such initiatives can lead to the production and transfer of knowledge, creating novel solutions in the public health sector. The example of Co-Immune contributes to paving the way for organizations and individuals to collaboratively tackle future global challenges. JMIR Publications 2022-01-21 /pmc/articles/PMC8817221/ /pubmed/35060917 http://dx.doi.org/10.2196/32125 Text en ©Camille Masselot, Bastian Greshake Tzovaras, Chris L B Graham, Gary Finnegan, Rathin Jeyaram, Isabelle Vitali, Thomas Landrain, Marc Santolini. Originally published in Journal of Participatory Medicine (https://jopm.jmir.org), 21.01.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in Journal of Participatory Medicine, is properly cited. The complete bibliographic information, a link to the original publication on https://jopm.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Masselot, Camille
Greshake Tzovaras, Bastian
Graham, Chris L B
Finnegan, Gary
Jeyaram, Rathin
Vitali, Isabelle
Landrain, Thomas
Santolini, Marc
Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study
title Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study
title_full Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study
title_fullStr Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study
title_full_unstemmed Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study
title_short Implementing the Co-Immune Open Innovation Program to Address Vaccination Hesitancy and Access to Vaccines: Retrospective Study
title_sort implementing the co-immune open innovation program to address vaccination hesitancy and access to vaccines: retrospective study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817221/
https://www.ncbi.nlm.nih.gov/pubmed/35060917
http://dx.doi.org/10.2196/32125
work_keys_str_mv AT masselotcamille implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT greshaketzovarasbastian implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT grahamchrislb implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT finnegangary implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT jeyaramrathin implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT vitaliisabelle implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT landrainthomas implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy
AT santolinimarc implementingthecoimmuneopeninnovationprogramtoaddressvaccinationhesitancyandaccesstovaccinesretrospectivestudy